Sacral neuromodulation and botulinum toxin for overactive neurogenic bladder in children

被引:0
|
作者
Aubert, D. [1 ]
Galli, G. [1 ]
Ramella, B. [1 ]
Moro-Enemuwe, A. [1 ]
Fotso-Kamden, A. [1 ]
机构
[1] CHU St Jacques, Serv Chrurg Pediat, F-25000 Besancon, France
来源
PELVI-PERINEOLOGIE | 2007年 / 2卷 / 03期
关键词
paediatric urology; neurogenic bladder; sacral neuromodulation; botulinum toxin;
D O I
10.1007/s11608-007-0137-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Overactive bladder is a major cause of urinary tract damage in children with congenital neurogenic bladder. Anticholinergics and bladder augmentation are the standard treatments. S3 sacral neuromodulation (InterStim (R)) and botulinum toxin injection (Botox (R) 12 mg/kg or Dysport (R)) into the detrusor muscle have recently been shown to be effective in adults. In children, the use of these treatments is still uncommon but the first results are as promising as those in adults and no adverse effects have been reported. In France, there is a need for additionnal randomized, multicenter trials to confirm the benefits of these two procedures in paediatric urology.
引用
收藏
页码:244 / 248
页数:5
相关论文
共 50 条
  • [1] Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder
    Kantartzis, Kelly
    Shepherd, Jonathan
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2012, 24 (05) : 331 - 336
  • [2] Cost Effectiveness of Sacral Neuromodulation and Botulinum Toxin A in Managing Refractory Overactive Bladder
    Hadidi, S.
    Atiiga, P. A.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 258 - 258
  • [3] Sacral neuromodulation and botulinum toxin-type A in overactive bladder: Timing of combination
    Bertapelle, M. P.
    Delta Ore, M. C.
    Bodo, G.
    Carone, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 247 - 247
  • [4] BOTULINUM TOXIN TREATMENT AND NEUROMODULATION FOR OVERACTIVE BLADDER
    Akman, R. Yavuz
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 10 (01) : 9 - 15
  • [5] SACRAL NEUROMODULATION IN PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER AFTER INITIAL BOTULINUM TOXIN THERAPY
    Smits, M.
    de Wachter, S.
    NEUROUROLOGY AND URODYNAMICS, 2012, 31 (06) : 828 - 829
  • [6] THE REFRACTORY OVERACTIVE BLADDER: SACRAL NEUROMODULATION VS. BOTULINUM TOXIN ASSESSMENT (ROSETTA)
    Amundsen, C.
    Richter, H.
    Menefee, S.
    Komesu, Y.
    Arya, L.
    Gregory, W. T.
    Myers, D.
    Zyczynski, H.
    Vasavada, S.
    Nolen, T.
    Wallace, D.
    Meikle, S.
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S23 - S24
  • [7] Sacral Neuromodulation in Patients with Idiopathic Overactive Bladder after Initial Botulinum Toxin Therapy
    Smits, Martijn A. C.
    Oerlemans, Dennis
    Marcelissen, Tom A. T.
    Van Kerrebroeck, Philip E. V.
    De Wachter, Stefan G. G.
    JOURNAL OF UROLOGY, 2013, 190 (06): : 2148 - 2152
  • [8] Efficacy of sacral neuromodulation in neurogenic overactive bladder: a systematic review
    TRAN NGOC AN HUYNH
    HE, C. A. R. L.
    HO, F. E. L. I. C. I. A. C. H. I. N. G. S. I. E. W.
    GAN, J. O. H. A. N., I
    YAO, H. E. N. R. Y. HAN-I
    O'CONNELL, H. E. L. E. N. E.
    BJU INTERNATIONAL, 2022, 129 : 84 - 85
  • [9] The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial
    Amundsen, Cindy L.
    Richter, Holly E.
    Menefee, Shawn
    Vasavada, Sandip
    Rahn, David D.
    Kenton, Kim
    Harvie, Heidi S.
    Wallace, Dennis
    Meikle, Susie
    CONTEMPORARY CLINICAL TRIALS, 2014, 37 (02) : 272 - 283
  • [10] The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA Trial
    Hall, Evelyn
    OBSTETRICS AND GYNECOLOGY, 2017, 129 (01): : 201 - 201